EGFRvIII is supposed to enhance GBM proliferation, angiogenesis, and invasiveness (145), and IL-13Rα2 is associated with GBM invasiveness and poor prognosis; both are GBM-specific antigens (146, 147). Here, IL13RA2 is linked to glioblastoma.